In current research scenario, an efficient synthesis has been developed for novel tetrazole scaffolds by single step multicomponent reaction. One of the most promising pathways is Ugi multi‐component process for the coupling of four different components in a single reaction step and isolate lead molecule which may serve better life to the society. The syntheses of tetrazoles were undertaken by the Ugi‐Multi Component approach with the condensation of aromatic aldehyde containing active pharmacophore, various aryl amines, isocyanide (cyclohexyl isocyanide) and TMS‐N3 under catalyst free reaction condition at room temperature. The structural conformation were carried out by most acceptable spectroscopic technique i.e. MS, IR, NMR and single crystal study (XRD) and potency of compounds (4a to 4h) were checked at NIH (National Institute of Health) use 60 different cell‐lines with respect to nine cancer panels among which compounds 4a and 4b have been found to be more potent against different cell lines.
Polyethylene glycol-400 (PEG-400) is a recyclable and rapid reaction medium for synthesizing a new series of 4-(3-[substitutedphenyl]-4,5-dihydro-1-phenyl-1H-pyrazol-5-yl)-1H-imidazoles in two-step procedures by condensation of 1H-imidazole-4-carbaldehyde and various acetophenones to form chalcones followed by base-catalyzed cyclization employing phenyl hydrazine in a catalyst-free approach. The way of projected approach provides easy work-up, less reaction time, avoids metal-based and toxic catalysts, high yield, and reduces the use of carcinogenic organic solvents. The synthesized scaffolds have been screened for their anti-microbial and anti-tubercular activity against a set of pathogens.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.